Neuropathic Pain Screening: Construct Validity in Patients With Sickle Cell Disease

Individuals with pain from sickle cell disease (SCD) are often treated for nociceptive pain, but recent findings indicate they may also have neuropathic pain. PAINReportIt, a computerized version of the McGill Pain Questionnaire, provides a potential subscale that is the summed number of selected ne...

Full description

Saved in:
Bibliographic Details
Published in:Western journal of nursing research 2020-02, Vol.42 (2), p.125-130
Main Authors: Powell-Roach, Keesha, Yao, Yingwei, Ezenwa, Miriam O., Schlaeger, Judith M., Suarez, Marie L., Molokie, Robert E., Wang, Zaijie Jim, Wilkie, Diana J.
Format: Article
Language:English
Subjects:
Adult
Anemia, Sickle Cell - complications
Chronic Pain
Computerization
Construct validity
Female
Humans
Male
Mass Screening
Medical screening
Nervous system
Neuralgia - diagnosis
Pain
Pain Measurement - statistics & numerical data
Questionnaires
Reproducibility of Results
Sickle cell disease
Surveys and Questionnaires
Validation studies
Validity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Individuals with pain from sickle cell disease (SCD) are often treated for nociceptive pain, but recent findings indicate they may also have neuropathic pain. PAINReportIt, a computerized version of the McGill Pain Questionnaire, provides a potential subscale that is the summed number of selected neuropathic pain quality words (PR-NNP), but it lacks construct validity. The study purpose was to ascertain PR-NNP construct validity in adults with SCD and chronic pain. In an outpatient setting, 186 participants completed the PAINReportIt, Neuropathic Pain Symptom Inventory (NPSI), and Leeds Assessment for Neuropathic Symptoms and Signs (S-LANSS). PR-NNP was moderately correlated with NPSI (r = .33, p < .001) and S-LANSS (r = .40, p < .001). Regression analysis indicated that PR-NNP and pain intensity, but not a nociceptive pain subscale, were significant predictors of NPSI and S-LANSS. Findings support construct validity of PR-NNP, which may be useful as a screening tool for neuropathic pain in patients with SCD.
ISSN:0193-9459
1552-8456
1552-8456
DOI:10.1177/0193945919836446